Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Periodic Fevers Syndrome × canakinumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2 Rheumatoid Arthritis, Systemic Juvenile 1 Periodic Fevers Syndrome 1 Neoplasm Metastasis 1 Mevalonate Kinase Deficiency 1 Lung Neoplasms 1 Cryopyrin-Associated Periodic Syndromes 1 Carcinoma 1 Bronchiolitis Obliterans Syndrome 1 Arthritis, Juvenile 1 Arthralgia 1

Interventions

secukinumab 1 canakinumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02911857 2018-08-20

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

Novartis

Phase 3 Completed

4 enrolled 7 charts

Periodic Fevers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡